125 related articles for article (PubMed ID: 36513934)
1. In Situ Hybridization (ISH) Combined with Immunohistochemistry (IHC) for Co-detection of EGFR RNA and Phosphorylated EGFR Protein in Lung Cancer Tissue.
Oliver A; Hagen J; Yang S; Kalyuzhny AE
Methods Mol Biol; 2023; 2593():221-232. PubMed ID: 36513934
[TBL] [Abstract][Full Text] [Related]
2. In Situ Hybridization (ISH) Combined with Immunocytochemistry (ICC) Co-detection of Phosphorylated EGFR in A431 Cultured Cells.
Hagen J; Oliver A; Kalyuzhny AE
Methods Mol Biol; 2023; 2593():213-220. PubMed ID: 36513933
[TBL] [Abstract][Full Text] [Related]
3. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
4. Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomas.
Coppock JD; Volaric AK; Mills AM; Gru AA
Hum Pathol; 2018 Dec; 82():282-288. PubMed ID: 30075155
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
[TBL] [Abstract][Full Text] [Related]
6. A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures.
Grabinski TM; Kneynsberg A; Manfredsson FP; Kanaan NM
PLoS One; 2015; 10(3):e0120120. PubMed ID: 25794171
[TBL] [Abstract][Full Text] [Related]
7. EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.
Thunnissen E; Bovée JV; Bruinsma H; van den Brule AJ; Dinjens W; Heideman DA; Meulemans E; Nederlof P; van Noesel C; Prinsen CF; Scheidel K; van de Ven PM; de Weger R; Schuuring E; Ligtenberg M
J Clin Pathol; 2011 Oct; 64(10):884-92. PubMed ID: 21947301
[TBL] [Abstract][Full Text] [Related]
8. HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Uehara T; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Sep; 85(3):373-8. PubMed ID: 25047676
[TBL] [Abstract][Full Text] [Related]
9. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
Jurmeister P; Vollbrecht C; Jöhrens K; Aust D; Behnke A; Stenzinger A; Penzel R; Endris V; Schirmacher P; Fisseler-Eckhoff A; Neumann J; Kirchner T; Büttner R; Merkelbach-Bruse S; Kreipe H; Jonigk D; Jochum W; Rodriguez R; Dietel M; Horst D; Hummel M; von Laffert M
Virchows Arch; 2021 Aug; 479(2):247-255. PubMed ID: 34173019
[TBL] [Abstract][Full Text] [Related]
10. Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.
Lim SJ; Cantillep A; Carpenter PM
Hum Pathol; 2013 Nov; 44(11):2590-6. PubMed ID: 24075600
[TBL] [Abstract][Full Text] [Related]
11. Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.
Schmid E; Klotz M; Steiner-Hahn K; Konen T; Frisk AL; Schatz C; Krahn T; von Ahsen O
Biotech Histochem; 2017; 92(6):425-435. PubMed ID: 28836864
[TBL] [Abstract][Full Text] [Related]
12. EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.
Wei EX; Anga AA; Martin SS; Jackson JG; Nordberg ML; Herrera GA; Turbat-Herrera EA
Mod Pathol; 2007 Sep; 20(9):905-13. PubMed ID: 17643093
[TBL] [Abstract][Full Text] [Related]
13. Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study.
Memon R; Prieto Granada CN; Harada S; Winokur T; Reddy V; Kahn AG; Siegal GP; Wei S
Clin Breast Cancer; 2022 Jan; 22(1):e123-e133. PubMed ID: 34120846
[TBL] [Abstract][Full Text] [Related]
14. Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization.
Shanmugalingam A; Hitos K; Pathmanathan N; Edirimmane S; Hughes TM; Ngui NK
Breast Cancer Res Treat; 2023 Feb; 198(1):143-148. PubMed ID: 36604351
[TBL] [Abstract][Full Text] [Related]
15. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma.
Soma S; Tsuta K; Takano T; Hatanaka Y; Yoshida A; Suzuki K; Asamura H; Tsuda H
Pathol Res Pract; 2014 Mar; 210(3):155-60. PubMed ID: 24355440
[TBL] [Abstract][Full Text] [Related]
17.
Canterbury CR; Fernandes H; Crapanzano JP; Murty VV; Mansukhani MM; Shu CA; Szabolcs M; Saqi A
JTO Clin Res Rep; 2021 Oct; 2(10):100223. PubMed ID: 34746883
[TBL] [Abstract][Full Text] [Related]
18. Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.
Gaber R; Watermann I; Kugler C; Reinmuth N; Huber RM; Schnabel PA; Vollmer E; Reck M; Goldmann T
Diagn Pathol; 2014 Sep; 9():165. PubMed ID: 25227424
[TBL] [Abstract][Full Text] [Related]
19. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.
Bhargava R; Gerald WL; Li AR; Pan Q; Lal P; Ladanyi M; Chen B
Mod Pathol; 2005 Aug; 18(8):1027-33. PubMed ID: 15920544
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous visualization and cell-specific confirmation of RNA and protein in the mouse retina.
Stempel AJ; Morgans CW; Stout JT; Appukuttan B
Mol Vis; 2014; 20():1366-73. PubMed ID: 25352743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
